tiprankstipranks
Treace Medical initiated with a Buy at Lake Street
The Fly

Treace Medical initiated with a Buy at Lake Street

Lake Street analyst Ben Haynor initiated coverage of Treace Medical (TMCI) with a Buy rating and $14.50 price target Foot and ankle orthopedics is a space “ignored by both investors and industry participants” despite being a $5B-plus global market growing at a 7%-8% compound annual growth rate, the analyst contends. The analyst, who thinks “the Street has fully digested (and overreacted to) the challenges Treace has faced,” sees Treace gearing up for several major portfolio additions in the first half of 2025 and adds that key CMS reimbursement “doubles tomorrow.”

Don't Miss Our New Year's Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App